05/04 - "Mr Simon Rushton, Managing Director stated: “Our newly appointed Board is finalising its assessment of the entire Macro mineral asset portfolio and we have identified that our Cane Bore and Catho Well projects are the two flagship exploration and development assets within the Company. We expedited a field visit to the two projects in order to assess logistics as well as refine our near term work programs and associated budgets. We have taken initial rock chip samples and submitted them to the laboratory for analysis. An extensive field-based program has been commissioned to commence at Cane Bore within the next fortnight. Additionally, we will also commence the permitting process within the next week for drilling to rapidly evaluate the scale and mineralisation potential of the Cane Bore Project. We look forward to providing our shareholders with regular updates on our exploration and development activities as they unfold in the weeks and months ahead.”
- Forums
- ASX - By Stock
- Ann: Site Visit Undertaken at Priority Development Projects
05/04 - "Mr Simon Rushton, Managing Director stated: “Our newly...
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add M4M (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.001(5.26%) |
Mkt cap ! $64.64M |
Open | High | Low | Value | Volume |
1.9¢ | 2.1¢ | 1.9¢ | $161.8K | 8.146M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 6205815 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 3211160 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 6205815 | 0.020 |
12 | 3515033 | 0.019 |
8 | 4433888 | 0.018 |
8 | 1787251 | 0.017 |
4 | 3522384 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 3211160 | 6 |
0.022 | 1238585 | 6 |
0.023 | 550000 | 2 |
0.024 | 1024722 | 3 |
0.025 | 53040 | 3 |
Last trade - 15.16pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
2.0¢ |
  |
Change
0.001 ( 2.56 %) |
|||
Open | High | Low | Volume | ||
2.0¢ | 2.0¢ | 1.9¢ | 9724443 | ||
Last updated 15.09pm 06/05/2024 ? |
Featured News
M4M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online